The history of cardiac pacing therapy must be viewed within the broader framework of electro-diagnosis and electro-therapy. Electro-therapy has a simple core concept: the use of an outside source of electricity to stimulate human tissue in various ways to produce a beneficial therapeutic effect. This has shown a prolonged, halting development through the ages, sometimes being looked upon as mysterious magic produced by complex machines. The field of paediatric open heart surgery gave a major impetus to the development of pacemakers since heart block often accompanied impeccably performed intra-cardiac repairs of congenital defects. This review deals various of aspects of pacemaker functioning, indications, contraindications and complications.
INTRODUCTION
Cardiac implantable electronic device (CIED) has been improving over the past few years and the number of patients using this device has continued to grow. The first pacemaker implant was introduced in 1958, which is asynchronous type and functioned for 3years. First on demand pacemaker (DVI) was introduced in 1964. In 1977 first atrial and ventricular demand pacing (DDD) came into use. Later on rate responsive pacing and resynchronization pacing were introduced but the automatic capture detection was introduced only in 1998. First human implants were done in 1980 by cardiac surgeons under general anesthesia. The devices were large and were placed in abdomen and required thorocotomy with perioperative mortality rate upto 9%. They lasted for 1.5years. Today they evolved as small devices placed in pectoral pocket under local anesthesia. Their battery lasted for 9years with perioperative mortality<1%.
PARTS OF PACEMAKERS
A pacemaker is a device that regulates the heart beat. They provide electrical stimuli to cause cardiac contraction when intrinsic cardiac activity is inappropriately slow or absent. It consists of
Generator
A Generator is a device containing a battery that provides the energy for sending electrical impulses to the heart and an electric circuitry that controls pacemaker operations, placed subcutaneously or
Electrode
Consists of Cathode (negative electrode), an electrode that is in contact with the heart tissue and Anode (positive electrode), an electrode that receives the electrical impulse after depolarization of cardiac tissue
DEFINITIONS

Pacing Rate
Frequency at which heart is stimulated in the absence of sensed cardiac activity. Mostly pacing pulse width is 0.5-1.5msec width, voltage around 2.5-5volts.
Pacing Threshold
Minimum energy required to capture the atria or ventricle. It is determined by intrinsic excitability of myocardium, duration of electrical pulse. Factors influencing are -Increase: propranolol, verapamil, antiarrhythmics, potassium, insulin, hypothyroidism &MI. Decrease: exercise, hyperthyroidism, hypoxia, glucocorticoids, sympathetic drugs.
Sensing
Sensing is the ability of the pacemaker to "see" when a natural (intrinsic) depolarization is occurring.
Pacemakers sense cardiac depolarization by measuring changes in electrical potential of myocardial cells between the anode and cathode.
Accurate Sensing
Accurate sensing enables the pacemaker to determine whether or not the heart has created a beat on its own. Ensures that undersensing and oversensing will not occur. Provides proper timing of the pacing pulse.
Undersensing
Pacemaker fails to sense P or R waves that should have been sensed
Oversensing
Pacemaker mistakes extra-cardiac activity for intrinsic cardiac events and generate an impulse.
A-V Interval
Maximum time interval between atrial and ventricular events. Starts with paced or spontaneous atrial beat and termination with initiation of paced or spontaneous ventricular event, takes 150-200msec usually.
Automatic interval
Time in milliseconds between successive pacemaker impulses
Escape Interval
Time the generator takes to emit an impulse in the absence of R wave.
R-Wave Sensitivity
No: of milivolts required to activate the sensing circuit and inhibit the pacing circuit.
Inhibited Pacemaker
Has a sensing circuit that detects R wave, compares it with standard and finally inactivates the pacing circuit if R-waves meet standard (ie., magnitude >1.5mv, slew rate>0.5v/sec, frequency >70bpm)
Rate Adaptive Pacemaker
Varies its automatic interval with the metabolic state or movement of the patient, it paces at baseline and increases the rate if patient exercises.
Blanking Period
Period after a paced or sensed event during which pacemaker does not respond to any ECG event.
Pacemakers can employ unipolar or bipolar leads. Over the past 15yrs bipolar leads has been in use.
Unipolar Pacemaker
It has only one electrode that contacts the heart at its tip, called the cathode. The anode is the pulse generator. Electromagnetic interference occurs more often in unipolar leads.
Bipolar Pacemaker
In this both anode and cathode are present on the heart. Provides more contact with the endocardium, needs lower current to pace. Less chance for cautery interference. 
Anti-Tachycardia Features
A -Atrium A -Atrium T -Triggered P -Simple P -Pacing
PACEMAKER CODES
Most Pacemakers Perform Four Functions:
• Stimulate cardiac depolarization
•
Sense intrinsic cardiac function
• Respond to increased metabolic demand by providing rate responsive pacing
• Provide diagnostic information stored by the pacemaker
The North American Society for Pacing and Electrophysiology (NASPE) and the British Pacing and Electrophysiology group (BSEP) has adapted a generic code which has been universally adapted to avoid confusion and improve communication [3] .
TYPES OF PACEMAKERS
• Asynchronous / Fixed rate: does not synchronise with intrinsic heart rate. Can be used safely in patients with no inrtrinsic ventricular activity. If patient has ventricular activity it competes with patients own conduction system causing ventricular tachycardia (R -on-T phenomenon) eg: VOO, AOO, DOO.
• Synchronous / Demand: It contains two circuits, one forms impulse, one acts as a sensor. When activated by an R wave, sensing circuit either triggers or inhibits the pacing circuit, called "Triggered" or "Inhibited" pacers. This is most frequently used pacer as it eliminates competition.eg: DDI, VVI/VVT, AAI/AAT.
• Single chamber: The pacing lead is implanted in the atrium or ventricle, depending on the chamber to be paced and sensed. It is asynchronous pacing. Single ventricular lead does not provide AV synchrony and single atrial lead does not provide ventricular backup if A-to-V conduction is lost.
• Dual chamber: This has two leads palced one in ventricle and one in atria. It is physiological pacing mode as ventricular systole is preceeded by atrial contraction and the atrial rate is the same as the ventricular rate. It provides atrial kick, optimizes left ventricular filling, AV synchrony and eventually improves cardiac outut. It minimizes AV valve regurgitation that occurs with other modes. Lower incidence of atrial fibrillation, new congestive heart failure, lowers risk of systemic embolism, stroke, mortality and higher survival rates.
• Programmable / nonprogrammable: Recently pacemakers have inbuilt rate modulation or programmability which allows them to increase the heart rate in response to increase physical activity (body movement, excersise) or physiological needs.
INDICATIONS OF PACEMAKERS
AOO: sinus node dysfunction like bradycardia with normal AV conduction.
VOO: significant bradycardia with normal sinus rhythm, chronic AF. It is a temporary mode.
AAI: sick sinus syndrome in the absence of AV node disease or atrial fibrillation.
VVI: symptomatic bradycardia caused by sinus node dysfunction, AV block, chronic atrial arrhythmias {AF}.
DVI: useful in dual chamber pacing when atrial sensing is not required. • Third-degree AV block at any anatomic level associated with any one of the following conditions:
• Bradycardia with symptoms presumed to be due to AV block.(Level of evidence: C).
• Arrhythmias and other medical conditions that require drugs that result in symptomatic bradycardia. (Level of evidence: C).
• Documented periods of asystole 3.0 seconds or any escape rate <40 beats per minute (bpm) in awake, symptom-free patients. (Level of evidence: B, C).
• After catheter ablation of the AV junction. (Level of evidence: B, C) There are no trials to assess outcome without pacing, and pacing is virtually always planned in this situation unless the operative procedure is AV junction modification.
• Postoperative AV block that is not expected to resolve. (Level of evidence: C).
• Neuromuscular diseases with AV block such as myotonic muscular dystrophy, Kearns-Sayre syndrome, Erb's dystrophy (limb-girdle), and peroneal muscular atrophy. (Level of evidence: B).
• Second-degree AV block regardless of type or site of block, with associated symptomatic bradycardia.
(Level of evidence: B).
Class II a 
IMPLANTABLE CARDIOVERTERDEFIBRILATOR (ICD'S)
These are designed to treat cardiac tachydysrythmias. They are capable of detecting a ventricular arrhythmia and delivering a defibrillator shock/cardioversion. They have antitachycardia pacing activity and have pacemaker function also(combo devices). Present day ICD's can terminate 98% of ventricular fibrillation episodes. These devices consists of electronic circuitry, power source, microprocessor, memory, leads and discharges from 1v-750v.
ICD's measure each cardiac R-R interval. IT reconfirms VT/VF and can differentiate VT from SVT. It gives a shock usually at 25 J. it takes 5-20 seconds to sense VT/VF and 5-15 sec to charge and 2.5-10 sec delay before next shock is administered. Delivers totally 5 shocks then pauses. During shock delivery if the patient has to be touched (while doing CPR) rubber gloves have to be worn for insulation.
INDICATIONS
Survivors of cardiac arrest due to VF or hemodynamically unstable VT Structural heart disease and spontaneous sustained VT LVEF <35% due to prior MI who are atleast 40dys post MI and DCM with EF<35% who are in NYHA class II or III Non sustained VT due to prior MI, LVEF<40% and inducible VF or sustained VT at electrophysiological study. 
CONCLUSION
The prevention and treatment of life-threatening brad arrhythmias have been revolutionized in the last half century by electronic pacemakers. The primary purpose of a pacemaker is to maintain an adequate heart rate, either because the heart's natural pacemaker is not fast enough, or there is a block in the heart's electrical conduction system. Most of the scientists and physicians involved in electro-therapy faced significant criticism and sometimes even derision by the contemporary scientific community. Yet the specialty moved steadily on gaining medical respectability and now helps countless patients all over the world.
